Mucopolysaccharidosis Treatment Global Market Report 2025

Published Feb 28, 2025

Length 200 Pages

SKU # BRC19655098

Description

Mucopolysaccharidosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mucopolysaccharidosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for mucopolysaccharidosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mucopolysaccharidosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Enzyme Replacement Therapy; Stem Cell Therapy

2) By Disease: Mucopolysaccharidosis- I; Mucopolysaccharidosis- II; Mucopolysaccharidosis-IV; Mucopolysaccharidosis-VI; Other Diseases

3) By Route Of Administration: Intravenous; Intracerebroventricular

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Enzyme Replacement Therapy: Idursulfase (Elaprase); Laronidase (Aldurazyme); Velaglucerase Alfa (Vpriv); Galsulfase (Naglazyme)

2) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation (HSCT); Umbilical Cord Blood Transplantation; Gene Therapy Approaches

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Mucopolysaccharidosis Treatment Market Characteristics
3. Mucopolysaccharidosis Treatment Market Trends And Strategies
4. Mucopolysaccharidosis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Mucopolysaccharidosis Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Mucopolysaccharidosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Mucopolysaccharidosis Treatment Market Growth Rate Analysis; 5.4. Global Mucopolysaccharidosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Mucopolysaccharidosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Mucopolysaccharidosis Treatment Total Addressable Market (TAM)
6. Mucopolysaccharidosis Treatment Market Segmentation: 6.1. Global Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Enzyme Replacement Therapy; Stem Cell Therapy; 6.2. Global Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Mucopolysaccharidosis- I; Mucopolysaccharidosis- II; Mucopolysaccharidosis-IV; Mucopolysaccharidosis-VI; Other Diseases; 6.3. Global Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Intravenous; Intracerebroventricular; 6.4. Global Mucopolysaccharidosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Specialty Clinics; Other End-Users; 6.5. Global Mucopolysaccharidosis Treatment Market, Sub-Segmentation Of Enzyme Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Idursulfase (Elaprase); Laronidase (Aldurazyme); Velaglucerase Alfa (Vpriv); Galsulfase (Naglazyme); 6.6. Global Mucopolysaccharidosis Treatment Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hematopoietic Stem Cell Transplantation (HSCT); Umbilical Cord Blood Transplantation; Gene Therapy Approaches
7. Mucopolysaccharidosis Treatment Market Regional And Country Analysis: 7.1. Global Mucopolysaccharidosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Mucopolysaccharidosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Mucopolysaccharidosis Treatment Market: 8.1. Asia-Pacific Mucopolysaccharidosis Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Mucopolysaccharidosis Treatment Market: 9.1. China Mucopolysaccharidosis Treatment Market Overview; 9.2. China Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Mucopolysaccharidosis Treatment Market: 10.1. India Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Mucopolysaccharidosis Treatment Market: 11.1. Japan Mucopolysaccharidosis Treatment Market Overview; 11.2. Japan Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Mucopolysaccharidosis Treatment Market: 12.1. Australia Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Mucopolysaccharidosis Treatment Market: 13.1. Indonesia Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Mucopolysaccharidosis Treatment Market: 14.1. South Korea Mucopolysaccharidosis Treatment Market Overview; 14.2. South Korea Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Mucopolysaccharidosis Treatment Market: 15.1. Western Europe Mucopolysaccharidosis Treatment Market Overview; 15.2. Western Europe Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Mucopolysaccharidosis Treatment Market: 16.1. UK Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Mucopolysaccharidosis Treatment Market: 17.1. Germany Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Mucopolysaccharidosis Treatment Market: 18.1. France Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Mucopolysaccharidosis Treatment Market: 19.1. Italy Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Mucopolysaccharidosis Treatment Market: 20.1. Spain Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Mucopolysaccharidosis Treatment Market: 21.1. Eastern Europe Mucopolysaccharidosis Treatment Market Overview; 21.2. Eastern Europe Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Mucopolysaccharidosis Treatment Market: 22.1. Russia Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Mucopolysaccharidosis Treatment Market: 23.1. North America Mucopolysaccharidosis Treatment Market Overview; 23.2. North America Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Mucopolysaccharidosis Treatment Market: 24.1. USA Mucopolysaccharidosis Treatment Market Overview; 24.2. USA Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Mucopolysaccharidosis Treatment Market: 25.1. Canada Mucopolysaccharidosis Treatment Market Overview; 25.2. Canada Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Mucopolysaccharidosis Treatment Market: 26.1. South America Mucopolysaccharidosis Treatment Market Overview; 26.2. South America Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Mucopolysaccharidosis Treatment Market: 27.1. Brazil Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Mucopolysaccharidosis Treatment Market: 28.1. Middle East Mucopolysaccharidosis Treatment Market Overview; 28.2. Middle East Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Mucopolysaccharidosis Treatment Market: 29.1. Africa Mucopolysaccharidosis Treatment Market Overview; 29.2. Africa Mucopolysaccharidosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Mucopolysaccharidosis Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Mucopolysaccharidosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Mucopolysaccharidosis Treatment Market Competitive Landscape And Company Profiles: 30.1. Mucopolysaccharidosis Treatment Market Competitive Landscape; 30.2. Mucopolysaccharidosis Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Mucopolysaccharidosis Treatment Market Other Major And Innovative Companies: 31.1. Novartis AG; 31.2. Sanofi S.A.; 31.3. Bristol-Myers Squibb Company; 31.4. GlaxoSmithKline plc; 31.5. Takeda Pharmaceutical Co. Ltd.; 31.6. Teva Pharmaceutical Industries Ltd.; 31.7. BioMarin Pharmaceuticals Inc.; 31.8. Mallinckrodt Pharmaceuticals; 31.9. Green Cross Corporation; 31.10. Sarepta Therapeutics Inc.; 31.11. Esteve SA; 31.12. JCR Pharmaceuticals Co. Ltd.; 31.13. Ultragenyx Pharmaceutical Inc.; 31.14. RegenxBio Inc.; 31.15. Sangamo Therapeutics Inc.
32. Global Mucopolysaccharidosis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Mucopolysaccharidosis Treatment Market
34. Recent Developments In The Mucopolysaccharidosis Treatment Market
35. Mucopolysaccharidosis Treatment Market High Potential Countries, Segments and Strategies: 35.1 Mucopolysaccharidosis Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Mucopolysaccharidosis Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Mucopolysaccharidosis Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now